Physician

Douglas Conaway, M.D.

According to 2025 Medicare claims, Douglas Conaway, M.D. (NPI: 1316944499) practices rheumatology in the Myrtle Beach-Conway-North Myrtle Beach, SC market, with the plurality of this provider's patient population coming from Horry, SC. This provider's primary affiliated billing organization is STRAND PHYSICIAN SPECIALISTS, PA (NPI: 1194707901; TIN: 570963173) and primary practice location at 29572-4612. Conaway is affiliated with the Aledade 153 SC MSSP Enhanced (ACO ID: A5356), participating under the MSSP model.

Conaway's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 306 traditional Medicare patients, billed 75,639 HCPCS/CPT codes, and received $1,041,054 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 4,467 prescription claims across 301 beneficiaries totaling $1,803,086 in drug costs, led by Humira(Cf) Pen (Adalimumab). 2015 DME data shows 11 claims. Open Payments data shows 179 records totaling $29,214. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $4,362,161 to $1,041,054. Concurrently, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $6,869 to $496.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,346	238,173	$4,362,161
2016	1,170	196,068	$3,909,001
2017	1,039	188,252	$3,673,110
2018	793	121,240	$2,579,847
2019	569	96,659	$2,009,430
2020	415	124,613	$2,237,577
2021	379	92,146	$1,595,953
2022	360	90,316	$1,174,596
2023	303	64,490	$997,301
2024	306	75,639	$1,041,054

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	655	5,869	$1,535,738
2016	620	6,430	$1,892,803
2017	492	5,602	$2,117,807
2018	393	4,892	$1,963,596
2019	318	4,267	$1,919,182
2020	292	4,182	$1,518,421
2021	309	3,973	$1,474,448
2022	290	3,582	$1,445,360
2023	316	4,430	$2,008,515
2024	301	4,467	$1,803,086

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	11	$1,080
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	216	484	$86
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	115	153	$47
36415	Insertion of needle into vein for collection of blood sample	149	277	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	116	205	$8
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	136	1,043	$1

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	27	756	$295,319
Tavneos	Avacopan	11	330	$181,147
Orencia	Abatacept	28	784	$165,381
Xeljanz Xr	Tofacitinib Citrate	14	660	$128,280
Humira	Adalimumab	13	364	$104,447

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	179	$29,214	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Douglas Conaway, M.D.?

Tedicare shows public-source Medicare data for Douglas Conaway, M.D. (NPI 1316944499), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Douglas Conaway, M.D. have ACO affiliation data?

Douglas Conaway, M.D. is shown with ACO affiliation data for Aledade 153 SC MSSP Enhanced (MSSP, ACO ID A5356).

What billing organization is linked to Douglas Conaway, M.D.?

Douglas Conaway, M.D. is linked to STRAND PHYSICIAN SPECIALISTS, PA (billing NPI 1194707901) in the available physician profile data.

Does Douglas Conaway, M.D. have Open Payments data?

Douglas Conaway, M.D. has 179 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.